Tumors are heterogenous masses of cells that rapidly divide. Many cells have different mutations, functions, and ways to ...

What does the future of cancer immunotherapy look like and how do we get there? Find out where we've been and where we're headed in A Report on Resistance: The Road to personalized ...

In a multi-institutional study published in Science Direct , researchers revealed that testing urine-based tumor DNA (utDNA) ...

Dr. Andre Henri Goy shared how CAR T-cell therapy led a retired pilot with lymphoma into remission, showing the impact of ...

On June 26, the BC Cancer Foundation announced that Dr. Brad Nelson will become the inaugural Lynda and Murray Farmer ...

The Interleukin-2 (IL-2) market is witnessing rapid growth due to advancements in cancer immunotherapy and autoimmune disease management. IL-2, a vital cytokine, promotes T-cell growth, with therapies ...

When Michelin Tunor from Nova Scotia was diagnosed with colon cancer, she expected immediate action. Instead, she was met ...